Status:
UNKNOWN
Headache Inducing Effect of NN414 in Migraine Patients
Lead Sponsor:
Danish Headache Center
Conditions:
Headache, Migraine
Eligibility:
All Genders
18-60 years
Phase:
NA
Brief Summary
To investigate the role of KATP channels on the cerebral hemodynamic in migraine patients.
Eligibility Criteria
Inclusion
- Criteria
- Migraine patients of both sexes.
- 18-60 years.
- 50-100 kg.
- Women of childbearing potential must use adequate contraception.
Exclusion
- Headache less than 48 hours before the tests start
- Daily consumption of drugs of any kind other than oral contraceptives
- Pregnant or nursing women.
- Cardiovascular disease of any kind, including cerebrovascular diseases.
- Diabetes mellitus and other endocrinologic disease
Key Trial Info
Start Date :
February 25 2022
Trial Type :
INTERVENTIONAL
Allocation :
ESTIMATED
End Date :
February 1 2023
Estimated Enrollment :
16 Patients enrolled
Trial Details
Trial ID
NCT04744129
Start Date
February 25 2022
End Date
February 1 2023
Last Update
February 13 2023
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Danish Headache Center
Copenhagen, Capital Region, Denmark, 2600